QA: Sarepta Therapeutics Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000873303_2018_Sarepta_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000873303, Sarepta Therapeutics Inc

  xvar xval
0 AssetsCurrent 1,228,644,000
1 IntangibleAssetsNetIncludingGoodwill 14,355,000
2 PropertyPlantAndEquipmentNet 43,156,000
3 remainder_Assets 21,809,000
4 LiabilitiesCurrent 88,332,000
5 LiabilitiesNoncurrent 5,539,000
6 remainder_Liabilities 424,876,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 122,682,000
9 ResearchAndDevelopmentExpense 166,707,000
10 remainder_Expenses 38,893,000
11 remainder_Revenues 154,584,000
12 remainder_NetIncome 123,010,000
13 remainder_ComprehensiveNetIncome -259,000
  yvar yval
0 Assets 1,307,964,000
1 Liabilities 518,747,000
2 Expenses 328,282,000
3 Revenues 154,584,000
4 StockholdersEquity 789,217,000
5 NetIncome -50,688,000
6 ComprehensiveNetIncome -50,817,500
7 BaseVar 1,216,423,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.83
9 EconomicCapitalRatio 2.91

Edgar->Model Mapping

Feature Distribution

Change over Time